Experts in topics including clinical toxicology, drug markets, social research and social care have been appointed to the Advisory Council on the Misuse of Drugs (ACMD), to help deliver the ACMD’s vital ongoing work.
The ACMD is an independent body which makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regulations.
The new appointees being announced today are:
- Professor Sarah Galvani, professor of Social Research and Substance Use at Manchester Metropolitan University
- Professor Judith Aldridge, professor of criminology at the University of Manchester
- Dr David Wood, consultant physician and clinical toxicologist at Guy’s and St Thomas’ Hospital, and Reader in clinical toxicology at King’s College London
The Chair of the Advisory Council on the Misuse of Drugs, Professor Owen Bowden-Jones, said:
I am delighted to welcome the new members to the ACMD. Their range of expertise will ensure that the Council continues to provide the best possible evidence-based advice on the harms of drug misuse. I look forward to working with each of them on a range of projects.
The 3 appointments to the ACMD will serve 3 year terms. Appointments to the ACMD attract no remuneration, and have been made in accordance with the Cabinet Office Code on Public Appointments.
The newly appointed members take up their positions today.